Growth Metrics

Veracyte (VCYT) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $72.2 million.

  • Veracyte's Total Current Liabilities rose 261.54% to $72.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.2 million, marking a year-over-year increase of 261.54%. This contributed to the annual value of $78.6 million for FY2024, which is 2839.93% up from last year.
  • Per Veracyte's latest filing, its Total Current Liabilities stood at $72.2 million for Q3 2025, which was up 261.54% from $76.4 million recorded in Q2 2025.
  • Veracyte's 5-year Total Current Liabilities high stood at $78.6 million for Q4 2024, and its period low was $32.7 million during Q1 2021.
  • Over the past 5 years, Veracyte's median Total Current Liabilities value was $61.2 million (recorded in 2023), while the average stood at $61.1 million.
  • In the last 5 years, Veracyte's Total Current Liabilities surged by 28228.35% in 2021 and then tumbled by 1047.28% in 2023.
  • Quarter analysis of 5 years shows Veracyte's Total Current Liabilities stood at $64.2 million in 2021, then dropped by 2.4% to $62.6 million in 2022, then decreased by 2.19% to $61.2 million in 2023, then grew by 28.4% to $78.6 million in 2024, then dropped by 8.24% to $72.2 million in 2025.
  • Its last three reported values are $72.2 million in Q3 2025, $76.4 million for Q2 2025, and $75.1 million during Q1 2025.